Market Newsdesk

Cerence and RV technology leader WFCO will unite their respective conversational AI and RV innovations to enhance safety, comfort and productivity

Abstracts highlight data from Phase 2 clinical trials – PDS0101-CRT combination study in cervical cancer and PDS0101-based triple combination study in HPV16-expressing cancers

Schlumberger Partners with Gradiant to Deliver Sustainable Production of Battery-Grade Lithium Compounds

Collaboration aims to maximize mineral recovery and reduce environmental footprint

HOUSTON & BOSTON–(BUSINESS WIRE)–
Schlumberger announced today that it has entered into a partnership with Gradiant, a global water solutions provider, to introduce a key sustainable technology into the production process for battery-grade lithium compounds.

As part of Schlumberger’s NeoLith Energy direct lithium extraction (DLE) and production flowsheet, Gradiant technology is used to concentrate the lithium solution and generate fresh water—a critical element in sustainable lithium production from brine.

“Proper natural resource management is essential in mineral production, and nowhere more so than in lithium,” said Gavin Rennick, president of Schlumberger’s New Energy business. “The unprecedented growth in demand for this critical mineral requires high-quality production without compromising sustainability. The integration of Gradiant technology into our direct lithium extraction (DLE) flowsheet has been key in our strategy to improve sustainability in the global lithium production industry.”

Gradiant’s new solution enhances the impact of the sustainable lithium extraction process—reduced time-to-market and environmental footprint. The technology enables high levels of lithium concentration in a fraction of the time required by conventional methods, while also reducing carbon emissions, energy consumption, and capital costs when compared to thermal-based technologies. This technology integration can be applied into new lithium mineral extraction and production sites, opening opportunities to untapped lithium production regions, as well as existing lithium production operations.

The collaboration will enable the lithium industry to meet surging mineral demand with a previously unattainable level of water utilization, by simultaneously lowering the consumption of fresh water and reducing wastewater.

“We are excited to be working with Schlumberger, with whom we are pioneering a new era of sustainable mineral resource recovery,” said Prakash Govindan, COO of Gradiant. “This is made possible by Gradiant’s deep understanding of the complex chemistry that underlies the production processes, which is then operationalized by machine learning and digital technology. The sustainability impact of the integrated Schlumberger process, combined with Gradiant solutions, is a game-changer for the lithium production market. This strategic partnership will enable the global expansion of Gradiant’s technology in this important industry.”

About Schlumberger

Schlumberger (NYSE: SLB) is a technology company that partners with customers to access energy. Our people, representing over 160 nationalities, are providing leading digital solutions and deploying innovative technologies to enable performance and sustainability for the global energy industry. With expertise in more than 120 countries, Schlumberger collaborates to create technology that unlocks access to energy for the benefit of all. In the world of new energy, Schlumberger leverages its intellectual and business capital to focus on low-carbon and carbon-neutral technologies, including ventures in the domains of hydrogen, lithium, energy storage, carbon capture, utilization and sequestration, geothermal power and geoenergy.

For more information, visit www.newenergy.slb.com

About Gradiant

Gradiant is a global solutions provider for advanced water and wastewater treatment. With a full suite of differentiated and proprietary end-to-end solutions, powered by the top minds in water, Gradiant serves its clients’ mission-critical operations in the world’s essential industries. Gradiant was founded at the Massachusetts Institute of Technology (MIT) and is uniquely positioned to address the world’s increasing challenges created by industrialization, population growth, and water stress. Today, with over 450 employees, Gradiant operates from its global headquarters in Boston, regional headquarters and global technology labs in Singapore, and offices across twelve countries.

For additional information, visit www.gradiant.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the U.S. federal securities laws — that is, statements about the future, not about past events. Such statements often contain words such as “expect,” “may,” “can,” “estimate,” “intend,” “anticipate,” “will,” “potential,” “projected” and other similar words. Forward-looking statements address matters that are, to varying degrees, uncertain, such as projected demand growth for battery-grade lithium, and other forecasts or expectations regarding global climate change. These statements are subject to risks and uncertainties, including, but not limited to, the inability to achieve net-negative carbon emissions goals; the inability to recognize intended benefits of the partnership; legislative and regulatory initiatives addressing environmental concerns, including initiatives addressing the impact of global climate change; the timing or receipt of regulatory approvals and permits; and other risks and uncertainties detailed in the companies’ public filings, including Schlumberger’s most recent Forms 10-K, 10-Q and 8-K filed with or furnished to the U.S. Securities and Exchange Commission. If one or more of these or other risks or uncertainties materialize (or the consequences of such a development changes), or should underlying assumptions prove incorrect, actual outcomes may vary materially from those reflected in our forward-looking statements. The forward-looking statements speak only as of the date of this press release, the parties disclaim any intention or obligation to update publicly or revise such statements, whether as a result of new information, future events or otherwise.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221004005771/en/

Media

Moira Duff – Director of External Communication, Schlumberger Limited

Tel: +1 (713) 375-3407

[email protected]

Felix Wang – Vice President of Marketing, Gradiant

Tel: +1 (973) 583-2695

[email protected]

Investors

Ndubuisi Maduemezia – Vice President of Investor Relations, Schlumberger Limited

Joy V. Domingo – Director of Investor Relations, Schlumberger Limited

Tel: +1 (713) 375-3535

[email protected]

KEYWORDS: United States North America Canada Texas Massachusetts

INDUSTRY KEYWORDS: Technology Other Energy Oil/Gas Batteries Alternative Energy Energy Artificial Intelligence Other Natural Resources Environment Mining/Minerals Sustainability Software Natural Resources Green Technology

MEDIA:

Logo

Alzamend Neuro Announces Addition of Healthy Subjects to Ongoing Phase IIA Clinical Trial for AL001 in Alzheimer’s Subjects

Alzamend pursuing additional indications of bipolar disorder, major depressive disorder and post-traumatic stress disorder for AL001

ATLANTA–(BUSINESS WIRE)–Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder, major depressive disorder (“MDD”) and post-traumatic stress disorder (“PTSD”), today announced it has dosed its first healthy adult subject in its Phase IIA multiple ascending dose (“MAD”) study of AL001 in subjects with dementia related to Alzheimer’s. This blinded, placebo-controlled trial (AL001-02) was initiated in May 2022 and is designed to evaluate the safety and tolerability of AL001 under multiple-dose, steady-state conditions and determine the maximum tolerated dose.

Alzamend is also pursuing AL001 for the treatment of bipolar disorder, MDD and PTSD. Based upon a recommendation by the U.S. Food and Drug Administration (“FDA”) after its review and commentary on Alzamend’s pre-investigational new drug (“IND”) briefing package for development of AL001 for bipolar disorder, MDD and PTSD, the ongoing clinical trial in Alzheimer’s patients has been expanded. As the safety and tolerability of AL001 would need to be tested in healthy and elderly adults before Alzamend could initiate later-stage testing of AL001 for bipolar disorder, MDD and PTSD, the addition of healthy and elderly adults to the on-going AL001-02 clinical trial would expedite the timing of further clinical trials. Alzamend will test AL001 in four healthy adult and elderly adult cohorts of eight subjects under MAD conditions.

AL001, a novel lithium-salicylate-L-proline engineered ionic cocrystal lithium delivery system, is under development as an oral treatment for patients with Alzheimer’s disease, and more recently for other neurodegenerative and neuropsychiatric disorders. AL001 has the potential to deliver benefits of marketed lithium carbonate while mitigating or avoiding current toxicities associated with lithium. In a Phase I relative bioavailability comparison of AL001 to lithium carbonate completed in March 2022, AL001 was shown to be bioequivalent at 50% less the dosage of lithium carbonate and the shapes of the lithium plasma concentration versus time curves were similar. Additionally, AL001 salicylate plasma concentrations were observed to be well tolerated and consistently within safe limits and the safety profiles of both AL001 and the marketed lithium carbonate capsule were benign.

“Adding healthy adult and elderly subjects to the Phase IIA MAD clinical trial is in response to recent FDA guidance regarding our forthcoming INDs for AL001 as a treatment of bipolar disorder, MDD and PTSD,” said Stephan Jackman, Chief Executive Officer of Alzamend. “We are one step closer to providing patients, caregivers and clinicians with a major improvement over current lithium-based treatments that can help over 40 million Americans suffering from Alzheimer’s, bipolar disorder, MDD and PTSD. We look forward to completing the AL001-02 study and further advancing clinical development of this promising potential therapeutic.”

About Alzamend Neuro

Alzamend is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s, bipolar disorder, MDD and PTSD. Our mission is to rapidly develop and market safe and effective treatments. Our current pipeline consists of two novel therapeutic drug candidates, AL001 – a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, salicylate, and L-proline, and ALZN002 – a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient’s immunological system to combat Alzheimer’s. Both of our product candidates are licensed from the University of South Florida Research Foundation, Inc. pursuant to royalty-bearing exclusive worldwide licenses.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as “believes,” “plans,” “anticipates,” “projects,” “estimates,” “expects,” “intends,” “strategy,” “future,” “opportunity,” “may,” “will,” “should,” “could,” “potential,” or similar expressions. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties. Forward-looking statements speak only as of the date they are made, and Alzamend undertakes no obligation to update any of them publicly in light of new information or future events. Actual results could differ materially from those contained in any forward-looking statement as a result of various factors. More information, including potential risk factors, that could affect Alzamend’s business and financial results are included in Alzamend’s filings with the U.S. Securities and Exchange Commission. All filings are available at www.sec.gov and on Alzamend’s website at www.Alzamend.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005399/en/

Email: [email protected] or call: 1-844-722-6333

KEYWORDS: Georgia United States North America

INDUSTRY KEYWORDS: Mental Health Nursing Seniors Neurology Clinical Trials Biotechnology Managed Care Pharmaceutical Consumer Health

MEDIA:

Logo

Afterpay’s New Monthly Payment Solution Gives Consumers More Ways to Pay

SAN FRANCISCO–(BUSINESS WIRE)–Afterpay, a leader in “Buy Now, Pay Later” payments, today introduced a new payment solution that give consumers even more choice, flexibility and time to pay, with transparent terms to support responsible spending – just in time for the busy holiday shopping season.

Consumers who select Afterpay’s monthly payment option can budget their money over a six or twelve month period for purchases between $400 and $4,000 with consumer-friendly payment terms¹ including:

• No late fees
• No compounding interest with a cap on total interest owed
• A clear view of what is owed at time of purchase which won’t increase during the course of the payment plan

Designed for purchases between $400 and $4,000, merchants can now offer Afterpay for more items in more categories without paying additional transaction fees or integration costs – while benefiting from new customer growth, increased sales, and higher average order values. Initially offered to existing customers making online purchases, the monthly payment solution will be available for in-person purchases in 2023.

“Our new offering is a natural extension of the Afterpay experience – giving customers a new way to take more control and have more choice in the way they pay,” said Lee Hatton, head of Cash App Asia Pacific. “We look forward to supporting customers with yet another smart budgeting tool.”

Starting today consumers can use Afterpay’s monthly payment option at US merchant websites including Bellacor.com, EyeBuyDirect, FWRD, and Your Mechanic among others, with additional merchant partners coming soon. The company plans to extend the offering to merchants outside the U.S. in 2023.

Afterpay gives consumers the ability to use their own money and pay over time without having to turn to expensive credit cards which can lead to revolving and compounding debt. Built from the ground up to help consumers pay responsibly, more than 98% of Afterpay transactions never incur a late fee and more than 90% of Afterpay transactions are paid with a debit card.²

Since 2020, US consumer spending on BNPL has increased 660 percent³. This is more than five times the rate of growth for debit card spending (43 percent) and credit card spending (8 percent).⁴

Afterpay’s monthly payment option is offered to existing customers in partnership with First Electronic Bank, Member FDIC. Merchants and shoppers can find more information about the monthly payment option here.

About Afterpay

Afterpay is transforming the way we pay by allowing anyone to buy products immediately and pay over time – enabling simple, transparent and responsible spending. We are on a mission to power an economy in which everyone wins.

Afterpay is offered by thousands of the world’s favorite retailers and used by millions of active global customers⁵. Afterpay is currently available in Australia, Canada, New Zealand, the United States and the United Kingdom, France, Italy and Spain, where it is known as Clearpay. Afterpay is a wholly owned subsidiary of Block, Inc. (NYSE: SQ).

__________________________

¹ You must be over 18, a resident of the U.S. and meet additional eligibility criteria to qualify. Loans through the Afterpay Pay Monthly program are underwritten and issued by First Electronic Bank, Member FDIC. A down payment may be required. APRs range from 0% to 35.99%, depending on eligibility. As an example, a 12 month $1,000 loan with 21% APR would have 11 monthly payments of $93.11 and 1 payment of $93.19 for a total payment of $1,117.40. Loans are subject to credit check and approval and are not available to residents of Hawaii, West Virginia, New Mexico and Nevada. Valid debit card, accessible credit report and acceptance of final terms required to apply. Estimated payment amounts shown on product pages exclude taxes and shipping charges, which are added at checkout. Click here for complete terms.

here to link to: Consumer Lending (Pay Monthly) Loan Agreement (*not* Installment Agreement for Afterpay pay-in-4)

² Figures as of June 30, 2022

³Source: The Next Generation Index, February 2022

⁴Source: The Next Generation Index, February 2022

⁵ Figures as of June 30

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005274/en/

Media Contact:

[email protected]

KEYWORDS: California United States North America

INDUSTRY KEYWORDS: Retail Technology Finance Banking Apps/Applications Other Consumer Blockchain Professional Services NFT Other Retail Electronic Commerce Digital Cash Management/Digital Assets Payments Software Consumer Internet

MEDIA:

Posted on October 5, 2022 8:03 am

OneMain Financial Extends Relief to Customers Impacted by Hurricane Ian

OneMain Financial Extends Relief to Customers Impacted by Hurricane Ian

NEW YORK–(BUSINESS WIRE)–OneMain Financial, the leader in offering nonprime customers responsible access to credit, has implemented a Borrower’s Assistance program to provide relief to customers in Florida affected by Hurricane Ian. The program will provide options to eligible customers, including deferring loan payments. The assistance will be available through Oct. 31 for customers in 17 counties in Florida: Charlotte, Collier, Desoto, Flagler, Hardee, Hillsborough, Lee, Manatee, Orange, Osceola, Pinellas, Polk, Putnam, Sarasota, Seminole, St. Johns and Volusia.

The company continues to monitor other states and counties that may have been impacted. Additionally, OneMain will host a community relief event on Saturday, Oct. 8 at 10 a.m. Eastern at the company’s branch in Port Charlotte, to distribute supplies to families in need.

“The devastating effects of Hurricane Ian have impacted so many communities in Florida,” said Joe LaCopo, Senior Managing Director at OneMain Financial. “Our thoughts are with those who are recovering, and our team is doing what we can to help those in need.”

OneMain has 69 branches and more than 400 team members in Florida. The company services nearly 170,000 customer accounts in the state.

In addition to a possible deferment, the program ensures that eligible borrowers who have contacted a OneMain representative and been accepted into the program do not incur late fees and returned payment fees.

Customers should call 844-791-3990 to discuss assistance options.

About OneMain Financial

OneMain Financial (NYSE: OMF) is the leader in offering nonprime customers responsible access to credit and is dedicated to improving the financial well-being of hardworking Americans. We empower our customers to solve today’s problems and reach a better financial future through personalized solutions available online and in 1,400 locations across 44 states. OneMain is committed to making a positive impact on the people and the communities we serve. For additional information, please visit OneMainFinancial.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005232/en/

Kelly Ogburn

410-537-9028

[email protected]

KEYWORDS: Florida New York United States North America

INDUSTRY KEYWORDS: Other Professional Services Other Philanthropy Finance Banking Professional Services Philanthropy Consumer Other Consumer

MEDIA:

Logo

Guilford County Schools Safely Usher In The New Academic Year With Evolv Technology

North Carolina district chose Evolv after seeing impressive results from nearby cities

WALTHAM, Mass.–(BUSINESS WIRE)–
Evolv Technology (NASDAQ: EVLV), the leader in AI-based weapons detection security screening, today announced its partnership with Guilford County Schools in North Carolina. Evolv’s state-of-the-art Evolv Express® screening solution began being used in nearly 20 of the district’s high schools starting with the 2022-2023 academic year.

After seeing the successful use of Evolv Express in the neighboring Charlotte-Mecklenburg school system, the district spoke with Evolv Technology about how Evolv Express could be used to screen for potential threats while enabling a comfortable entry into school for students.

Evolv Express allows for a faster and better security process as people can walk through without always having to stop or undergo invasive screening while the system works to detect and pinpoint the location of concealed weapons. Traditional metal detectors at schools can cause backups at entrances and delays to the start of the school day, as students are subject to a manual screening process, as well as tend to make students feel less safe and unsettled. With Evolv Express in place, there is no hassle of undergoing an invasive, hands-on security check at the start of the day.

“The Evolv system allows us to add another layer of security for our schools, without detracting from the learning environment,” said Mike Richey, executive director of emergency management at Guilford County Schools. “After successfully launching the system in all high schools at the start of the school year, we are now using it for sporting events and other large gatherings.”

Guilford County Schools is using 44 Evolv Express screening systems across 19 high schools. The technology will help keep tens of thousands of students, educators, and staff safe in the state’s third-largest school district. In addition to its use in Charlotte-Mecklenburg schools, Evolv Express is currently in use in more than 26 schools across the U.S. including schools in Spartanburg, South Carolina, Fayette County, West Virginia and Champaign, Illinois.

“Our vision is a safer world for people wherever they gather,” said Peter George, CEO of Evolv Technology. “Working with Guilford County, and a growing list of schools around the country, is at the center of that vision and allows schools to keep the focus on providing a quality education.”

About Evolv Technology

Evolv Technology (NASDAQ: EVLV) is transforming human security to make a safer, faster, and better experience for the world’s most iconic venues and companies as well as schools, hospitals, and public spaces, using industry leading artificial intelligence (AI)-powered weapons detection and analytics. Its mission is to transform security to create a safer world to work, learn, and play. Evolv has digitally transformed the gateways in places where people gather by enabling seamless integration combined with powerful analytics and insights. Evolv’s advanced systems have scanned more than 350 million people, second only to the Department of Homeland Security’s Transportation Security Administration (TSA) in the United States. Evolv has been awarded the U.S. Department of Homeland Security (DHS) SAFETY Act Designation as a Qualified Anti-Terrorism Technology (QATT) as well as the Security Industry Association (SIA) New Products and Solutions (NPS) Award in the Law Enforcement/Public Safety/Guarding Systems category. Evolv Technology®, Evolv Express®, Evolv Insights®, and Evolv Cortex AI® are registered trademarks or trademarks of Evolv Technologies, Inc. in the United States and other jurisdictions. For more information, visit https://evolvtechnology.com.

Forward-looking Statements

Certain statements in this press release may constitute “forward-looking” statements and information, within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995 that relate to our current expectations and views of future events. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. These forward-looking statements are subject to risks, uncertainties and assumptions, some of which are beyond our control. In addition, these forward-looking statements reflect our current views with respect to future events or our Company’s performance and are not a guarantee of future performance. Actual outcomes may differ materially from the information contained in the forward-looking statements as a result of a number of factors, including, without limitation, the risk factors set forth in our Annual Report on Form 10-K for the year ended on December 31, 2021, that was filed with the SEC on March 28, 2022, as may be updated in other filings we make with the SEC. These statements reflect management’s current expectations regarding future events and operating performance and speak only as of the date of this press release. You should not put undue reliance on any forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005314/en/

Media:

Alexandra Smith Ozerkis

[email protected]

Investors:

Brian Norris

[email protected]

KEYWORDS: United States North America North Carolina Massachusetts

INDUSTRY KEYWORDS: Technology Other Technology Public Policy/Government Other Education Primary/Secondary Data Management Education Artificial Intelligence Public Safety

MEDIA:

Logo

Twist Bioscience to Present at JSNN NanoImpacts 2022

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Steffen Hellmold, senior vice president, business development for data storage, will present at the Joint School of Nanoscience and Nanoengineering (JSNN) NanoImpacts 2022: Semiconductor Synthetic Biology and Beyond taking place October 13-15, 2022 in Greensboro, NC.

Mr. Hellmold will participate in the panel “Perspectives on SemiSynBio: Progress to Date; What’s Missing? And What’s Next?” on Thursday, October 13 at 2:10 PM ET. He will give a keynote speech on Friday, October 14 at 9:00 AM ET on progress being made towards delivering DNA data storage at scale.

The NanoImpacts 2022 Conference highlights progress being made towards achieving goals laid out in the 2018 SemiSynBio Roadmap (SSBR), refines the vision for future initiatives and explores potential synthetic biology and nanomaterial processes and application opportunities beyond the scope of the SSBR.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn | YouTube

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005222/en/

For Twist Bioscience:

Angela Bitting

SVP, Corporate Affairs

925- 202-6211

[email protected]

KEYWORDS: United States North America California

INDUSTRY KEYWORDS: Other Health Research General Health Pharmaceutical Technology Semiconductor Genetics Clinical Trials Science Nanotechnology Biotechnology Health

MEDIA:

Logo

TrustRadius Names Docebo a 2022 Tech Cares Award Winner for Demonstrating Strong Corporate Social Responsibility

Learning suite provider recognized for fostering an environment of diversity, equity, and inclusion and giving back to the community

TORONTO–(BUSINESS WIRE)–
Docebo Inc. (NASDAQ: DCBO; TSX: DCBO) (“Docebo” or the “Company”), a leading artificial intelligence (AI)-powered learning suite provider, today announced that TrustRadius, the most trusted research and review platform, has recognized Docebo with a 2022 Tech Cares Award. This third-annual award celebrates companies that have gone above and beyond to provide impactful corporate social responsibility (CSR) programs for their employees and surrounding communities.

“Docebo has earned a 2022 Tech Cares award for demonstrating a strong commitment to corporate social responsibility,” said Megan Headley, VP of Research at TrustRadius. “Docebo released their first ESG report earlier this year, outlining their initiatives and how they support their values of accountability, impact, and togetherness. These initiatives included creating new resource groups to foster inclusion for their employees and prioritizing renewal energy sources for 80% of their offices.”

To be accepted for the TrustRadius Tech Cares Award, each nominated organization had to be a B2B technology company that demonstrated impactful CSR initiatives in one of the following categories: volunteerism, diversity, equity, and inclusion programs, charitable giving, and fundraising, support for in-office and remote employees, or environmental sustainability initiatives. Everyone was welcome to nominate an organization for this award, including those who work for or with the company. The TrustRadius research team thoroughly vetted all nominations, and the supporting materials were provided by the nominated companies.

“It’s an honor to receive this recognition from TrustRadius for the second year in a row,” said Claudio Erba, CEO and Founder of Docebo. “We believe it is important to inspire a better future through technology, by living by our core values and embracing corporate social responsibility to effect positive change. We couldn’t have accomplished all that we have without the amazing group of employees and employee resource groups who work tirelessly behind the scenes on many of our CSR initiatives, and our loyal partners and customers who continue to support our efforts every step of the way.”

About Docebo

Docebo is redefining the way enterprises leverage technology to create and manage content, deliver training, and understand the business impact of their learning experiences. With Docebo’s multi-product learning suite, enterprises around the world are equipped to tackle any learning challenge and create a true learning culture within their organization.

Learn why our customers love Docebo by visiting ourcustomer stories page.

About TrustRadius: TrustRadius is the most trusted research and review platform for business leaders to find and select the right software for their needs. Decision-makers across industries rely on verified, peer-based guidance and research from TrustRadius. Vendors engage and convert high-intent buyers by telling their unique story through rich reviews. Over 12 million visitors a year create and engage with high-quality review content and data on Trustradius.com. Headquartered in Austin, TX, TrustRadius was founded by successful entrepreneurs and is backed by Mayfield Fund, LiveOak Venture Partners, and Next Coast Ventures.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221005005239/en/

Ronda Morra

Global Director, PR & Communications

[email protected]

781-589-7226

KEYWORDS: North America Canada

INDUSTRY KEYWORDS: Technology Other Technology

MEDIA:

Logo